List of insiders holdings for Apogee Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 2026-01-22 20:07:15 | 0 7,144,300 | 7,144,300 | Form 4 |
| 2 | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 2026-01-22 20:00:19 | 6,047,027 0 | 6,047,027 | Form 13D |
| 3 | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 2026-01-22 20:00:19 | 6,047,027 0 | 6,047,027 | Form 13D |
| 4 | HENDERSON MICHAEL THOMAS Chief Executive Officer | 2026-02-13 20:00:15 | 1,172,987 0 | 1,172,987 | Form 4 |
| 5 | Shah Nimish P Director | 2025-10-15 16:10:06 | 0 365,853 | 365,853 | Form 4 |
| 6 | Dambkowski Carl Chief Medical Officer | 2026-02-04 20:02:30 | 346,563 0 | 346,563 | Form 4 |
| 7 | Henderson Jane Chief Financial Officer | 2026-02-04 20:01:01 | 183,371 0 | 183,371 | Form 4 |
| 8 | Bollinger Lisa Director | 2025-06-20 20:00:12 | 14,461 0 | 14,461 | Form 4 |
| 9 | Fox Jennifer A. Director | 2025-06-20 20:01:12 | 14,461 0 | 14,461 | Form 4 |
| 10 | Gottesdiener Andrew Director | 2025-06-20 20:02:14 | 14,461 0 | 14,461 | Form 4 |
| 11 | JONES WILLIAM A JR Director | 2025-06-20 20:03:24 | 14,461 0 | 14,461 | Form 4 |
| 12 | McKenna Mark C. Director | 2025-06-20 20:04:24 | 14,461 0 | 14,461 | Form 4 |